Russia registers second vaccine for covid-19 but fails production target – Coronavirus


The goal set by Russia to have 30 million doses of the Sputnik V vaccine by the end of 2020 is not achievable, due to production setbacks. However, Vladimir Putin has already announced a new vaccine against covid-19, at a time when the country is fighting against the exponential increase in daily infections.
Russian President Vladimir Putin announced that the Vector Virology and Biotechnology Center has registered a new vaccine against covid-19, named EpiVacCorona. The tests and clinical trials carried out on the new vaccine ended on September 30 and, according to Putin, “have been successfully completed”.

This possible cure, tested by Deputy Prime Minister Tatiana Gólikova, does not cancel, according to Putin, the production of the first vaccine. Quite the opposite. Russia will simultaneously increase the production of the two vaccines in order to satisfy the needs of the national market, at a time when the country is reaching records in the number of daily covid-19 cases.
Registered on August 11, the first Sputnik V vaccine placed high hopes in Russia. Putin argues that it was the first vaccine registered worldwide and that its name refers to a Russian feat, the first artificial satellite launched by the Soviet Union in 1957.
Despite still being tested for safety and efficacy, Sputnik V has been approved by the Russian government and will be administered to the population, in order to face the exponential increase in infections.

By the end of the month, Russia now expects to produce 40,000 doses of its vaccines, with a maximum of 2.3 million doses by the end of the year. As for the export of these possible cures, Putin believes that each country will have to “deal with its own production”.


Please enter your comment!
Please enter your name here